Desloratadine is a selective peripheral histamine Н1 receptor antagonist that does not cause a sedative effect. Desloratadine is the primary active metabolite of loratadine.
Relief of symptoms associated with:
allergic rhinitis (see the Pharmacological Properties section);
urticaria (see the Pharmacological Properties section).
Eridez-Darnitsa is intended for oral administration. Adults and children over 12 years old should take 1 tablet (5 mg) once per day regardless of food intake to eliminate symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria. The tablet should be swallowed whole with water.